Dr. AntoniRibas

Dr. Antoni Ribas, MD, PhD, is a globally renowned medical oncologist and leading authority in cancer immunotherapy, celebrated for his transformative research in immune checkpoint blockade and translational melanoma therapy. He serves as Professor of Medicine, Surgery, and Molecular and Medical Pharmacology at the David Geffen School of Medicine at UCLA, Director of the UCLA Jonsson Comprehensive Cancer Center Tumor Immunology Program, and Director of the Parker Institute for Cancer Immunotherapy Center at UCLA. Dr. Ribas earned his medical degree and PhD from the University of Barcelona, completed his residency in Internal Medicine at Vall d’Hebron University Hospital, and his fellowship in Hematology/Oncology at UCLA. He is board-certified in Internal Medicine and Medical Oncology and is internationally recognized for his leadership in advancing cancer immunotherapy from bench to bedside.